Evolution of the Average Target: Dolby Laboratories, Inc.

Evolution of the Target Price: Dolby Laboratories, Inc.

Changes in Analyst Recommendations: Dolby Laboratories, Inc.

77348dcfcfd2673d99264.VBHGrpQGTOrWk8habb9WsR3IwYK-bXDGHmbnzGEfexw.HV2u5OVAFbiB34I9PuYY01mfmODMOyL3ejWxlBB8HG08fInhxjEKqYbcgQ~5df284eb4dc5c27b3b8b7f9e02c7e4be
19/11 Barrington Trims Price Target on Dolby Laboratories to $95 From $100, Keeps Outperform Rating MT
05/25/05 Baird Initiates Dolby Laboratories at Neutral With $74 Price Target MT
15/25/15 Dolby Laboratories' Immersive Media Innovation, Strategic Partnerships to Drive Long-Term Growth, Tigress Financial Partners Says MT
15/25/15 Tigress Adjusts Price Target on Dolby Laboratories to $114 From $112, Maintains Buy Rating MT
03/24/03 Barrington Upgrades Dolby Laboratories to Outperform From Market Perform, Price Target is $100 MT
04/23/04 Rosenblatt Adjusts Price Target on Dolby Laboratories to $98 From $93, Maintains Buy Rating MT
03/23/03 Rosenblatt Adjusts Price Target on Dolby Laboratories to $90 From $85, Maintains Buy Rating MT
18/22/18 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform as Economic Challenges Results in Lower Volumes MT
18/22/18 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform MT
07/22/07 Rosenblatt Adjusts Price Target on Dolby Laboratories to $85 From $90, Maintains Buy Rating MT
14/22/14 Tigress Financial Cuts Dolby Laboratories' Price Target to $116 From $128 'on Near-Term Valuation Rerating;' Buy Rating Kept MT
24/22/24 Rosenblatt Starts Dolby Laboratories at Buy With $90 Price Target MT
13/22/13 Barrington Research Lowers Price Target for Dolby Laboratories to $90 From $115, Maintains Outperform Rating MT
02/21/02 Dolby Laboratories : Barrington Upgrades Dolby Laboratories to Outperform From Market Perform "as New Initiatives Supplement Progress", Sets $115 Price Target MT
29/21/29 Dolby Laboratories : B. Riley Adjusts Dolby Laboratories' Price Target to $89 From $79, Keeps Neutral Rating MT
04/21/04 Dolby Laboratories : Barrington Research Downgrades Dolby Laboratories to Market Perform From Outperform MT
13/20/13 Dolby Laboratories : JP Morgan Adjusts Price Target for Dolby Laboratories to $90 From $78, Maintains Overweight Rating MT
13/20/13 Dolby Laboratories : B. Riley Adjusts Dolby Laboratories' Price Target to $79 from $73, Keeps Neutral Rating MT
13/20/13 Dolby Laboratories : Barrington Research Adjusts PT on Dolby Laboratories to $95 From $83, Citing 'Meaningful Positive Momentum;' Outperform Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+37.03%
+5.85%
+44.69%
+28.04%
- - +55.38%
Average +34.20%
Weighted average by Cap. +15.97%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
57.65USD
Average target price
79.00USD
Spread / Average Target
+37.03%
High Price Target
90.00USD
Spread / Highest target
+56.11%
Low Price Target
62.00USD
Spread / Lowest Target
+7.55%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. DLB Stock
  4. Consensus Dolby Laboratories, Inc.
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!